消息面上，据报道，马斯克近日在社交媒体上表示，其脑机接口公司Neuralink将于2026年开始对脑机接 口设备进行"大规模生产"。开源证券认为，脑机接口行业正处于技术突破、政策支持、机器人生态协同 预期等多重因素驱动下的高增蓄势期，根据Precedence Research数据，预计到2034年全球脑机接口市场 规模将增长到约124亿美元，2025-2034年CAGR为17%。 智通财经APP获悉，脑机概念股早盘走强，截至发稿，南京熊猫电子股份(00553)涨15.53%，报5.58港 元；心玮医疗-B(06609)涨11.63%，报60.95港元；微创脑科学(02172)涨8.67%，报12.28港元。 国金证券指出，近期政策端对医疗器械创新支持力度较高，国家药监局在北京召开脑机接口医疗器械工 作推进会，积极推动脑机接口器械更快更好上市应用。脑机接口赛道应用场景多元化、产品及研发路径 丰富，未来潜在空间巨大，在产品注册及医保立项政策加持下有望加速实现商业化普及。 ...

1月5日，脑机接口板块高开，创新医疗、三博脑科、南京熊猫、岩山科技、美好医疗涨停，倍益康涨超20%，翔宇医疗涨超15%，诚益通、麦澜德、爱朋医 疗涨超10%。 近日，美国企业家埃隆.马斯克在社交媒体上表示，其脑机接口公司Neuralink将于2026年开始大规模生产脑机接口设备，并转向更加精简和几乎完全自动化 的外科手术流程。 拓展阅读 从硅谷的手术机器人精准植入柔性电极，到中国实验室里"北脑二号"的千通道解码算法突破；从让瘫痪者用意识打游戏、发微博，到用超声波无创调控大脑 情绪——脑机接口不再只是科幻片的桥段，它正在医疗领域掀起新一轮技术浪潮。 2026年新年伊始，美国科技富豪马斯克在社交媒体上宣布，他的脑机接口公司Neuralink今年将开启"大规模量产"（high volume），并转向更精简、全自动化 的外科手术流程。 与此同时，中国的脑机接口公司也正在加速临床，并呈现多种技术路线并行的格局。一场集体"插脑"竞赛进入冲刺阶段。 海内外多种技术路线并行 在复旦大学附属华山医院，由毛颖院长带领的脑机接口团队在过去一年里完成了中国第一例"全植入式脑机接口"临床试验。患者"小董"（董辉）是一位因车 祸导致脊髓 ...

消息面上，据报道，马斯克近日在社交媒体上表示，其脑机接口公司Neuralink将于2026年开始对脑机接 口设备进行"大规模生产"。开源证券认为，脑机接口行业正处于技术突破、政策支持、机器人生态协同 预期等多重因素驱动下的高增蓄势期，根据Precedence Research数据，预计到2034年全球脑机接口市场 规模将增长到约124亿美元，2025-2034年CAGR为17%。 国金证券指出，近期政策端对医疗器械创新支持力度较高，国家药监局在北京召开脑机接口医疗器械工 作推进会，积极推动脑机接口器械更快更好上市应用。脑机接口赛道应用场景多元化、产品及研发路径 丰富，未来潜在空间巨大，在产品注册及医保立项政策加持下有望加速实现商业化普及。 脑机概念股早盘走强，截至发稿，南京熊猫（600775）电子股份(00553)涨15.53%，报5.58港元；心玮医 疗-B(06609)涨11.63%，报60.95港元；微创脑科学(02172)涨8.67%，报12.28港元。 ...

每经AI快讯，1月5日，沪指高开0.46%，深成指高开0.80%，创业板指高开0.84%，人脑工程、贵金属、 石油石化等板块指数涨幅居前。脑机接口概念表现活跃，创新医疗涨停，美好医疗、三博脑科20cm涨 停，倍益康、爱朋医疗、翔宇医疗涨超10%，博拓生物、伟思医疗跟涨。 （文章来源：每日经济新闻） ...

Satellite Internet - Blue Arrow Aerospace's IPO on the Sci-Tech Innovation Board has been accepted, aiming to raise 7.5 billion yuan, with a focus on reusable rockets [1] - Starlink announced it will provide free broadband service to the people of Venezuela for one month [3] Artificial Intelligence - Wall Street is seeing active IPOs and financing, with companies like Biran Technology experiencing a significant stock price increase, and Suiyuan Technology completing IPO guidance [4] - Google and Anthropic reported strong demand for TPU, while there are rumors of significant price increases for NVIDIA and AMD GPUs starting next month [4] Semiconductor - The Big Fund has increased its stake in SMIC H-shares, and TrendForce has revised upward its expectations for DRAM and NAND contract price increases in Q1 2026 [5] - TSMC has received U.S. permission to transport equipment to its Nanjing plant and plans to raise prices for advanced processes [6] Robotics - Reports suggest that Tesla's Optimus V3 mass production review has been completed, with seven Chinese companies as core suppliers, targeting a production capacity of 50,000 to 100,000 units by the end of the year [7] New Energy - Tianci Materials has released an annual forecast, confirming that Q4 performance is on track [9] Nuclear Fusion - The all-superconducting tokamak experiment has achieved significant physical breakthroughs, providing a basis for high-density operation [10] - The first nuclear fusion conference of the year will be held from January 16 to 17 in Hefei [11] Autonomous Driving - Tesla owners have achieved "full self-driving across the United States" for the first time [13] Digital Currency - State-owned banks will start paying interest on digital RMB real-name wallet balances at current account rates from January 1 [14] Market News - The New Year speech mentioned advancements in artificial intelligence, semiconductors, aerospace, and robotics across multiple sectors [15] - Companies are required to disclose annual performance forecasts by January 31 [16] - Market pricing clues for 2026 indicate sustained high growth, broad recovery, U.S. inflation, and Chinese domestic demand [17] Market Observation - On the last trading day before the holiday, the transaction volume reached 2.05 trillion yuan, with indices closing in the green but not reaching 4,000 points [18] - The satellite internet sector successfully crossed the year-end, with funds remaining in the market, and there is potential for healthy pullbacks to provide better entry opportunities [18]

Core Insights - The brain-computer interface (BCI) industry is entering a "golden development period," characterized by significant advancements from laboratory innovations to clinical applications [1][2][3] Group 1: Technological Advancements - In 2025, significant milestones were achieved in BCI technology, including the first clinical trials of flexible micro-invasive BCI systems and the first intervention-assisted trials for restoring limb function [2][3] - Three main technological routes are developing in parallel: invasive, semi-invasive, and non-invasive techniques, with invasive methods being central to medical rehabilitation due to their high signal acquisition precision [3][4] - The semi-invasive BCI system developed by Borui Kang Technology requires only a small hole in the skull for implantation, allowing patients to control movements through thought [4] Group 2: Clinical Applications and Breakthroughs - Clinical breakthroughs include the successful restoration of walking in patients with severe spinal cord injuries through innovative BCI technologies [3][4] - A variety of new BCI applications are emerging, such as a visual reconstruction system for visually impaired patients and a wireless, fully implanted BCI product that has completed its first clinical trial [10][11] Group 3: Industry Growth and Policy Support - The establishment of pricing regulations for BCI services by the National Medical Insurance Administration marks a significant step in integrating this technology into public healthcare [6][8] - Various regions, including Shanghai and the Guangdong-Hong Kong-Macau Greater Bay Area, are forming BCI innovation clusters to enhance industry capabilities and foster collaboration among enterprises, hospitals, and research institutions [7][8] Group 4: Future Prospects - Experts predict that 2026 will be a pivotal year for the BCI industry, with advancements in multi-disciplinary integration, clinical scalability, and diverse application scenarios [9][10] - The anticipated mass production of certain BCI devices will pave the way for a diversified application ecosystem, enhancing the potential for widespread commercial use [10][11]

Core Insights - The article highlights the rapid advancements in brain-computer interface (BCI) technology in China, showcasing significant clinical achievements and the emergence of a collaborative ecosystem for innovation in this field [1][5][10] Group 1: Clinical Breakthroughs - Patients with paralysis have shown remarkable recovery, such as playing games like "Snake" and "Mario Kart" through thought control, demonstrating the potential of BCI technology [1] - In 2025, several pioneering clinical trials were conducted, including the world's first intervention-assisted BCI for restoring limb function and the first clinical implantation of domestically developed BCI chips [2][3] - Invasive, semi-invasive, and non-invasive BCI technologies are developing concurrently, with invasive methods providing high signal accuracy and non-invasive methods expanding into broader markets due to lower costs [3][4] Group 2: Technological Advancements - The semi-invasive BCI system NEO has been developed, requiring only a small hole in the skull for implantation, allowing patients to control movements through thought [4] - Significant breakthroughs in core components and decoding algorithms have been achieved, enhancing the stability and precision of BCI devices [4] Group 3: Industry Development - The establishment of pricing regulations for BCI services by the National Medical Insurance Administration marks a significant step towards integrating this technology into healthcare [5] - A national BCI industrial cluster is forming, with various regions, including Shanghai and Jiangxi, actively promoting BCI innovation and development [6][7] Group 4: Future Prospects - Experts predict that 2026 will be a pivotal year for the BCI industry, characterized by multi-disciplinary integration and diverse application scenarios [8] - Recent innovations, such as a visual reconstruction system for visually impaired patients and a fully implanted wireless BCI, indicate a trend towards practical applications of BCI technology [9][10]

Key Points - The article emphasizes the importance of systematic and practical strategies in investment banking [2] - It discusses the positive economic outlook for early 2026, supported by improved PMI data and increased foreign capital inflow [8][9] - The article highlights the potential for a bull market in 2026, driven by improved supply-demand dynamics in the manufacturing sector and increased asset allocation towards equities [9] - It identifies key themes for investment in the spring, including AI, commercial aerospace, and nuclear fusion, as well as the impact of government policies on consumption and investment [9] - The valuation analysis of A-shares shows that various indices are at different historical percentiles, indicating potential investment opportunities in certain sectors [12][13] - The article notes significant adjustments in precious metals due to changes in margin requirements at CME and differing views within the Federal Reserve regarding interest rate cuts [14] - It discusses the launch of national venture capital guiding funds and the global competition for future industries, including quantum technology and hydrogen energy [21]

Core Viewpoint - Neuralink plans to start large-scale production of brain-machine interface devices in 2026, with a focus on highly automated surgical procedures that eliminate the need to remove the dura mater for electrode insertion [2][4]. Group 1: Neuralink's Developments - Neuralink aims to simplify the surgical process and enhance efficiency and cost-effectiveness through automation, marking a significant advancement in invasive brain-machine interface technology [2][4]. - The company has completed a $650 million Series E funding round in 2025, achieving a valuation of approximately $9 billion [4]. - As of September 2025, 12 individuals have undergone Neuralink device implantation, with a total usage time exceeding 15,000 hours [4]. Group 2: Market and Industry Trends - The brain-machine interface market is projected to grow to approximately $12.4 billion by 2034, with a CAGR of 17% from 2025 to 2034 [5]. - The anticipated commercialization of brain-machine interfaces is expected to transition from medical necessity to applications in AI and robotics [2][5]. - Related companies in the A-share market are expected to benefit from Neuralink's scaling production and technological breakthroughs [5]. Group 3: Future Prospects - Neuralink's future product upgrades include increasing electrode channels to 3,000 by 2026 and 10,000 by 2027, with a long-term goal of over 25,000 channels by 2028 [4]. - The collaboration between Neuralink and the Optimus robot is expected to redefine human-robot interaction and explore the potential of integrating human brain functions with AI [3][4].

更多资料加入知识星球:水木调研纪要 关注公众号:水木纪要 脑机接口深度报告 20260104 摘要 Q&A 更多资料加入知识星球:水木调研纪要 关注公众号:水木纪要 接口的医保价格进行了单独立项,并有 11个省份跟进了相关费用的设定。7月 份,工信部联合七部门发布了《脑机接口推动产业创新发展实施意见》,在全国 范围内推广两步走的产业目标,并强调非侵入式产品在工业制造和安全生产中的 应用。10月28日,《十五规划建议》将脑机接口列为六大未来产业之一,并定 位为新的经济增长点。12月26日,国家药监局将植入式脑机接口器械纳入优先 审批高端医疗器械目录,这将加快相关产品的注册审批流程。 脑机接口全球市场规模如何测算? 我们对全球脑机接口市场规模进行了详细测算,将其划分为医疗和消费教育两大 类市场。目前医疗健康场景是主要关注点,包括运动功能障碍重建、语言功能障 碍重建、视觉障碍功能重建以及意识和认知障碍恢复等应用场景。在这些领域, 我们针对中风、癫痫、脊髓损伤、帕金森等疾病患者进行了渗透率假设。例如, 到 2030 年帕金森病领域渗透率预计可达 15%,到 2040 年整体渗透率可达到 15-20%。 消费教育领域虽 ...